Advance Cystic Fibrosis Drug Trial

lifestyle June 16, 2026 at 4:25 pm 1 month ago

Jerusalem-based SpliSense has secured up to $13 million in funding from the Cystic Fibrosis Foundation to advance its Phase 2b clinical ...